Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands Inc TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis operations, Distribution business, Beverage alcohol business and Wellness business. The Cannabis operations, which encompasses the production, distribution, sale, co-manufacturing and advisory services of both medical and adult-use cannabis. The Beverage alcohol operations, which encompasses the production, marketing and sale of beverage alcohol products. The Distribution operations, which encompasses the purchase and resale of pharmaceuticals products to customers. The Wellness products, which encompasses hemp foods and cannabidiol (CBD) products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Hop Valley, Revolver, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Comment by DaveInCalgaryon Feb 17, 2024 10:53am
233 Views
Post# 35885767

RE:Tilray Brands - German Cannabis Legalization Update

RE:Tilray Brands - German Cannabis Legalization UpdateAphria / Tilray has a well developed Medical Cannabis business from
German Govt spec'd 'In Country' Medical Cannabis greenhouse facilities, German, established Medical Cannabis distribution and importation, CC Pharma (CC Tilray) to 13,000 pharmacies in Germany, established since 1999. Which is Tilray's plan since 2018. 

"Our country of 83 million, which currently has between 200,000-300,000 medical patients, will see its number of medical cannabis patients multiply between seven and ten times, into the millions,” Kouparanis pointed out' (Bloomwell's CEO)

"The reclassification of cannabis in Germany as a non-narcotic will set the stage for more affordable and accessible medical cannabis for all patients. Our country of 83 million, which currently has between 200,000-300,000 medical patients, could eventually see its number of medical cannabis patients multiply into the millions.
 
Germany is on the verge of ending prohibition and ushering in a paradigm shift. The number of patients benefiting from treatment with medical cannabis, in particular, will increase rapidly in the coming year.
 
Germany will become the biggest medical cannabis market in the world next year, so investors should look to Germany, where there are opportunities to do business with experienced companies that are already engaged with patients and are utilising data on medical cannabis supply and demand"
 

<< Previous
Bullboard Posts
Next >>